Could the Blackmores share price fall another 18%?

It’s been a problematic year for Blackmores, with its share price collapsing a little more than 30% since January.

The stock market can be brutal, maddening and optimistic all at once.

The long-term price action of Blackmores is indeed something that would stir elation amongst early investors. In January 1999, Blackmores stock traded at just A$5.00 per share. Almost two decades later – in January 2016 – the Blackmores share price stood at an ambitious A$210.00 per share; a tidy increase of 4,100%.

The last few years by comparison have proven to be significantly less fortuitous. Had you invested around those peaks and held until today, you capital would have more than been cut in half.

Indeed, at the time of writing, Blackmores stock currently trades at the A$84.95 mark; a far cry from its relatively recent all-time peak. Such is the brutality of the markets, I guess.

A recent article from Reuters explains what triggered this calamity well:

‘Blackmores, once an investors’ darling as China’s appetite for health products drove double-digit annual sales growth, is now struggling with tougher import rules and a slowdown in consumer spending in its biggest overseas market.’

Chinese regulation has indeed minted – and stalled the growth of many aspirational ASX-listed companies. A2 Milk for example has been on a multi-year growth spree thanks to China’s fast growing middle-class. Bellamys by comparison saw its share price hammered as the company vied for – but never received the required regulatory approval to sell its infant formula in Chinese retail stores. As we previously wrote:

‘That approval never came – and indeed, remains pending.’

The Blackmores share price and Credit Suisse

Blackmores – like Bellamys – isn’t quite out of the woods just yet either.

Specifically, according to the banking giant Credit Suisse, there remains more downside still for the Blackmores share price. Specifically, the investment bank just today downgraded the stock from ‘neutral’ to ‘underperform’ and hit Blackmores with a 12-month price target of A$69.00 per share.

At current price levels and not including dividends, this would imply a potential further share price decline of around 18.7%.

Importantly, Credit Suisse does somewhat hopefully postulate that there is potential of a turnaround story or even a takeover – potentially like the one Bellamys recently received.

Yet on the basis of valuation, Blackmores still trades at a heady set of estimated multiples: 31 times FY20 EPS and 26.5 times FY21 EPS. In step with this, the bank has reduced its EPS forecasts for Blackmores, which currently sit at A$2.79 (FY20), A$3.27 (FY21) and A$3.59 (FY22)

Mind you, even with this underperform rating and EPS reduction, Credit Suisse was impressed by Blackmores recent management shake-up and critically believes that growth will resume in FY21.

The question remains then: can investors wait that long?

Or maybe a better question: is there actually a turnaround story here as Credit Suisse so suggests?

Only time will tell.

Practise trading Australian stocks like Blackmores and a2 Milk with an IG demo account now

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

Please see important Research Disclaimer.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
liveprices.javascriptrequired
liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.